Combo therapy cuts prostate cancer death rate by halfDecember 16th, 2008 - 4:29 pm ICT by ANI
London, Dec 16 (ANI): Adding radiation therapy to standard drug treatment can cut prostate cancer death rate by half, according to a new study.
Researchers said that the effects are so striking that radiotherapy combined with hormonal (drug) treatment should be the new standard for these patients, reports the Independent.
Potentially curative treatments for early, non-aggressive cancer include surgery to remove the prostate gland and targeted radiotherapy.
However, when the tumour is starting to break out and invade surrounding tissues, doctors consider that “the horse has bolted”. In these circumstances a strategy of containment rather than cure is adopted.
Hormone, or endocrine, therapy which stops tumours being fuelled by testosterone is currently one of the most common ways of tackling locally advanced prostate cancer.
However, new findings suggest that survival can be dramatically improved if radiotherapy is used as well.
In the study, more than 800 men in Scandinavia were randomly allocated to receive radiotherapy with hormonal treatment or hormonal treatment alone.
Over ten years, almost one in four (23.9 per cent) of those who received the hormonal treatment alone had died compared with just over one in 10 (11.9 per cent) of those who had the two treatments combined hormonal treatment with radiotherapy.
Recurrence of the cancer, defined by rising levels of the blood marker prostate specific antigen (PSA), was nearly three times higher among patients only given hormone therapy.
However, side effects including urinary incontinence and impotence were slightly more frequent among the patients who had radiotherapy.
Led by Professor Anders Widmark, from Umea University in Sweden, the research team said that the “significant superiority” of the combined treatment and its similar side effects suggest it “should be the new standard of care for these patients.”
The study appears online in The Lancet. (ANI)
- Hormone therapy 'doubles survival chances in men with prostate cancer' - Mar 25, 2011
- New method detects aggressive prostate cancer - Aug 09, 2012
- Oregano can help protect against prostate cancer - Apr 25, 2012
- Slowing down prostate cancer by starving its cells - Nov 03, 2011
- New protein drives prostate cancer cells to 'suicide' - Feb 01, 2011
- Experimental drug for advanced prostate cancer shows promise - Apr 15, 2010
- Aspirin reduces risk of cancer recurrence in prostate cancer patients - May 03, 2011
- Now, remote sensing to kill prostate cancer - Oct 26, 2010
- Prostate cancer patients who remain disease free for 5yrs after treatment less likely to have recurr - Jul 03, 2009
- High level of testosterone may speed up prostate cancer - Jul 31, 2012
- Vaccine extends life of brain cancer patients - Apr 19, 2012
- 20-year-long study finds prostate cancer screening doesn't cut death risk - Apr 01, 2011
- Combo therapy may overcome Herceptin-resistant breast cancer - Mar 14, 2011
- New ultrasound technology can accurately spot prostate cancer tumours - Dec 09, 2010
- Potent anticancer drug isolated from weed - Jul 10, 2012
Tags: aggressive cancer, cancer death rate, containment, curative treatments, endocrine therapy, hormone therapy, lancet, prostate cancer, prostate gland, prostate specific antigen, radiation therapy, radiotherapy, recurrence, study researchers, tumour, tumours, umea university, university in sweden, urinary incontinence, widmark